Software - Application
Compare Stocks
5 / 10Stock Comparison
SURG vs LBRDA vs ATUS vs TMUS vs VZ
Revenue, margins, valuation, and 5-year total return — side by side.
Telecommunications Services
Telecommunications Services
Telecommunications Services
Telecommunications Services
SURG vs LBRDA vs ATUS vs TMUS vs VZ — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Software - Application | Telecommunications Services | Telecommunications Services | Telecommunications Services | Telecommunications Services |
| Market Cap | $11M | $5.18B | $539M | $209.55B | $199.16B |
| Revenue (TTM) | $50M | $261M | $8.59B | $90.53B | $138.19B |
| Net Income (TTM) | $-42M | $-2.74B | $-1.87B | $10.54B | $17.17B |
| Gross Margin | -38.6% | 77.8% | 51.6% | 54.3% | 55.7% |
| Operating Margin | -78.8% | 8.8% | -1.3% | 20.4% | 21.2% |
| Forward P/E | — | 3.1x | — | 18.4x | 9.5x |
| Total Debt | $5M | $1.75B | $250M | $122.27B | $200.59B |
| Cash & Equiv. | $12M | $57M | $1.01B | $5.60B | $19.05B |
SURG vs LBRDA vs ATUS vs TMUS vs VZ — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| SurgePays, Inc. (SURG) | 100 | 3.6 | -96.4% |
| Liberty Broadband C… (LBRDA) | 100 | 26.8 | -73.2% |
| Altice USA, Inc. (ATUS) | 100 | 6.4 | -93.6% |
| T-Mobile US, Inc. (TMUS) | 100 | 193.6 | +93.6% |
| Verizon Communicati… (VZ) | 100 | 82.3 | -17.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: SURG vs LBRDA vs ATUS vs TMUS vs VZ
Each card shows where this stock fits in a portfolio — not just who wins on paper.
SURG is the clearest fit if your priority is sleep-well-at-night and defensive.
- Lower volatility, beta 1.27, Low D/E 30.1%, current ratio 2.95x
- Beta 1.27, current ratio 2.95x
LBRDA is the #2 pick in this set and the best alternative if value and stability is your priority.
- Lower P/E (3.1x vs 9.5x)
- Beta 0.29 vs ATUS's 1.94
Among these 5 stocks, ATUS doesn't own a clear edge in any measured category.
TMUS ranks third and is worth considering specifically for growth exposure and long-term compounding.
- Rev growth 8.5%, EPS growth 0.6%, 3Y rev CAGR 3.5%
- 405.7% 10Y total return vs VZ's 41.9%
- 8.5% revenue growth vs LBRDA's -100.0%
- 4.9% ROA vs SURG's -242.4%, ROIC 8.1% vs -229.7%
VZ carries the broadest edge in this set and is the clearest fit for income & stability.
- Dividend streak 11 yrs, beta -0.10, yield 5.7%
- 12.4% margin vs LBRDA's -10.5%
- 5.7% yield, 11-year raise streak, vs TMUS's 1.9%, (3 stocks pay no dividend)
- +14.6% vs SURG's -80.0%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 8.5% revenue growth vs LBRDA's -100.0% | |
| Value | Lower P/E (3.1x vs 9.5x) | |
| Quality / Margins | 12.4% margin vs LBRDA's -10.5% | |
| Stability / Safety | Beta 0.29 vs ATUS's 1.94 | |
| Dividends | 5.7% yield, 11-year raise streak, vs TMUS's 1.9%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +14.6% vs SURG's -80.0% | |
| Efficiency (ROA) | 4.9% ROA vs SURG's -242.4%, ROIC 8.1% vs -229.7% |
SURG vs LBRDA vs ATUS vs TMUS vs VZ — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
SURG vs LBRDA vs ATUS vs TMUS vs VZ — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
VZ leads in 2 of 6 categories
ATUS leads 1 • TMUS leads 1 • SURG leads 0 • LBRDA leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — SURG and LBRDA and VZ each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
VZ is the larger business by revenue, generating $138.2B annually — 2743.4x SURG's $50M. VZ is the more profitable business, keeping 12.4% of every revenue dollar as net income compared to LBRDA's -10.5%. On growth, SURG holds the edge at +2.9% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $50M | $261M | $8.6B | $90.5B | $138.2B |
| EBITDAEarnings before interest/tax | -$39M | -$3.7B | $1.6B | $29.9B | $47.6B |
| Net IncomeAfter-tax profit | -$42M | -$2.7B | -$1.9B | $10.5B | $17.2B |
| Free Cash FlowCash after capex | -$26M | $303M | $163M | $10.7B | $19.8B |
| Gross MarginGross profit ÷ Revenue | -38.6% | +77.8% | +51.6% | +54.3% | +55.7% |
| Operating MarginEBIT ÷ Revenue | -78.8% | +8.8% | -1.3% | +20.4% | +21.2% |
| Net MarginNet income ÷ Revenue | -83.4% | -10.5% | -21.8% | +11.6% | +12.4% |
| FCF MarginFCF ÷ Revenue | -50.9% | +116.1% | +1.9% | +11.8% | +14.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | +2.9% | -100.0% | -2.3% | +10.6% | +2.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +47.2% | -24.6% | -25.0% | -12.0% | -53.4% |
Valuation Metrics
ATUS leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
At 11.6x trailing earnings, VZ trades at a 42% valuation discount to TMUS's 19.9x P/E. On an enterprise value basis, ATUS's 7.7x EV/EBITDA is more attractive than TMUS's 10.1x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $11M | $5.2B | $539M | $209.5B | $199.2B |
| Enterprise ValueMkt cap + debt − cash | $4M | $6.9B | $25.6B | $326.2B | $380.7B |
| Trailing P/EPrice ÷ TTM EPS | -0.23x | -1.93x | -8.59x | 19.92x | 11.63x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 3.09x | — | 18.40x | 9.54x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | 0.67x | — |
| EV / EBITDAEnterprise value multiple | — | — | 7.70x | 10.11x | 8.00x |
| Price / SalesMarket cap ÷ Revenue | 0.18x | — | 0.06x | 2.37x | 1.44x |
| Price / BookPrice ÷ Book value/share | 0.70x | 0.90x | — | 3.70x | 1.89x |
| Price / FCFMarket cap ÷ FCF | — | — | 3.61x | 20.26x | 9.90x |
Profitability & Efficiency
TMUS leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
TMUS delivers a 17.8% return on equity — every $100 of shareholder capital generates $18 in annual profit, vs $-10 for SURG. SURG carries lower financial leverage with a 0.30x debt-to-equity ratio, signaling a more conservative balance sheet compared to TMUS's 2.07x. On the Piotroski fundamental quality scale (0–9), TMUS scores 6/9 vs SURG's 2/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -10.1% | -35.5% | — | +17.8% | +16.4% |
| ROA (TTM)Return on assets | -2.4% | -22.6% | -156.2% | +4.9% | +4.4% |
| ROICReturn on invested capital | -2.3% | -0.3% | -0.8% | +8.1% | +8.0% |
| ROCEReturn on capital employed | -177.3% | -0.3% | -0.8% | +9.8% | +8.8% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 3 | 5 | 6 | 4 |
| Debt / EquityFinancial leverage | 0.30x | 0.31x | — | 2.07x | 1.90x |
| Net DebtTotal debt minus cash | -$7M | $1.7B | -$762M | $116.7B | $181.5B |
| Cash & Equiv.Liquid assets | $12M | $57M | $1.0B | $5.6B | $19.0B |
| Total DebtShort + long-term debt | $5M | $1.7B | $250M | $122.3B | $200.6B |
| Interest CoverageEBIT ÷ Interest expense | -40.65x | -28.58x | — | 5.33x | 4.39x |
Total Returns (Dividends Reinvested)
VZ leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in TMUS five years ago would be worth $14,858 today (with dividends reinvested), compared to $503 for ATUS. Over the past 12 months, VZ leads with a +14.6% total return vs SURG's -80.0%. The 3-year compound annual growth rate (CAGR) favors VZ at 13.5% vs SURG's -49.3% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -67.5% | -25.7% | +9.9% | -2.5% | +20.0% |
| 1-Year ReturnPast 12 months | -80.0% | -61.0% | -31.8% | -20.2% | +14.6% |
| 3-Year ReturnCumulative with dividends | -87.0% | -54.8% | -37.0% | +40.0% | +46.3% |
| 5-Year ReturnCumulative with dividends | -93.3% | -77.6% | -95.0% | +48.6% | +1.6% |
| 10-Year ReturnCumulative with dividends | -99.1% | -37.6% | -88.0% | +405.7% | +41.9% |
| CAGR (3Y)Annualised 3-year return | -49.3% | -23.2% | -14.3% | +11.9% | +13.5% |
Risk & Volatility
Evenly matched — TMUS and VZ each lead in 1 of 2 comparable metrics.
Risk & Volatility
TMUS is the less volatile stock with a -0.27 beta — it tends to amplify market swings less than ATUS's 1.94 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. VZ currently trades 91.4% from its 52-week high vs SURG's 16.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.27x | 0.29x | 1.94x | -0.27x | -0.10x |
| 52-Week HighHighest price in past year | $3.45 | $102.38 | $2.98 | $261.56 | $51.68 |
| 52-Week LowLowest price in past year | $0.46 | $35.98 | $1.59 | $181.36 | $10.60 |
| % of 52W HighCurrent price vs 52-week peak | +16.1% | +35.2% | +63.4% | +74.0% | +91.4% |
| RSI (14)Momentum oscillator 0–100 | 41.4 | 30.5 | 57.9 | 46.9 | 46.8 |
| Avg Volume (50D)Average daily shares traded | 366K | 182K | 956K | 5.5M | 24.1M |
Analyst Outlook
VZ leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: LBRDA as "Buy", ATUS as "Buy", TMUS as "Buy", VZ as "Hold". Consensus price targets imply 716.4% upside for ATUS (target: $15) vs 9.2% for VZ (target: $52). For income investors, VZ offers the higher dividend yield at 5.75% vs TMUS's 1.88%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | — | $158.00 | $15.43 | $254.08 | $51.56 |
| # AnalystsCovering analysts | — | 13 | 36 | 54 | 60 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | +1.9% | +5.7% |
| Dividend StreakConsecutive years of raises | — | — | 3 | 3 | 11 |
| Dividend / ShareAnnual DPS | — | — | — | $3.64 | $2.71 |
| Buyback YieldShare repurchases ÷ mkt cap | +5.7% | 0.0% | 0.0% | +4.8% | 0.0% |
VZ leads in 2 of 6 categories (Total Returns, Analyst Outlook). ATUS leads in 1 (Valuation Metrics). 2 tied.
SURG vs LBRDA vs ATUS vs TMUS vs VZ: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is SURG or LBRDA or ATUS or TMUS or VZ a better buy right now?
For growth investors, T-Mobile US, Inc.
(TMUS) is the stronger pick with 8. 5% revenue growth year-over-year, versus -100. 0% for Liberty Broadband Corporation (LBRDA). Verizon Communications Inc. (VZ) offers the better valuation at 11. 6x trailing P/E (9. 5x forward), making it the more compelling value choice. Analysts rate Liberty Broadband Corporation (LBRDA) a "Buy" — based on 13 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — SURG or LBRDA or ATUS or TMUS or VZ?
On trailing P/E, Verizon Communications Inc.
(VZ) is the cheapest at 11. 6x versus T-Mobile US, Inc. at 19. 9x. On forward P/E, Liberty Broadband Corporation is actually cheaper at 3. 1x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — SURG or LBRDA or ATUS or TMUS or VZ?
Over the past 5 years, T-Mobile US, Inc.
(TMUS) delivered a total return of +48. 6%, compared to -95. 0% for Altice USA, Inc. (ATUS). Over 10 years, the gap is even starker: TMUS returned +405. 7% versus SURG's -99. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — SURG or LBRDA or ATUS or TMUS or VZ?
By beta (market sensitivity over 5 years), T-Mobile US, Inc.
(TMUS) is the lower-risk stock at -0. 27β versus Altice USA, Inc. 's 1. 94β — meaning ATUS is approximately -812% more volatile than TMUS relative to the S&P 500. On balance sheet safety, SurgePays, Inc. (SURG) carries a lower debt/equity ratio of 30% versus 2% for T-Mobile US, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — SURG or LBRDA or ATUS or TMUS or VZ?
By revenue growth (latest reported year), T-Mobile US, Inc.
(TMUS) is pulling ahead at 8. 5% versus -100. 0% for Liberty Broadband Corporation (LBRDA). On earnings-per-share growth, the picture is similar: T-Mobile US, Inc. grew EPS 0. 6% year-over-year, compared to -1718. 2% for Altice USA, Inc.. Over a 3-year CAGR, SURG leads at 6. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — SURG or LBRDA or ATUS or TMUS or VZ?
T-Mobile US, Inc.
(TMUS) is the more profitable company, earning 12. 4% net margin versus -1050. 2% for Liberty Broadband Corporation — meaning it keeps 12. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: TMUS leads at 21. 2% versus -68. 6% for SURG. At the gross margin level — before operating expenses — LBRDA leads at 77. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is SURG or LBRDA or ATUS or TMUS or VZ more undervalued right now?
On forward earnings alone, Liberty Broadband Corporation (LBRDA) trades at 3.
1x forward P/E versus 18. 4x for T-Mobile US, Inc. — 15. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ATUS: 716. 4% to $15. 43.
08Which pays a better dividend — SURG or LBRDA or ATUS or TMUS or VZ?
In this comparison, VZ (5.
7% yield), TMUS (1. 9% yield) pay a dividend. SURG, LBRDA, ATUS do not pay a meaningful dividend and should not be held primarily for income.
09Is SURG or LBRDA or ATUS or TMUS or VZ better for a retirement portfolio?
For long-horizon retirement investors, T-Mobile US, Inc.
(TMUS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 27), 1. 9% yield, +405. 7% 10Y return). Altice USA, Inc. (ATUS) carries a higher beta of 1. 94 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (TMUS: +405. 7%, ATUS: -88. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between SURG and LBRDA and ATUS and TMUS and VZ?
These companies operate in different sectors (SURG (Technology) and LBRDA (Communication Services) and ATUS (Communication Services) and TMUS (Communication Services) and VZ (Communication Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: SURG is a small-cap quality compounder stock; LBRDA is a small-cap quality compounder stock; ATUS is a small-cap quality compounder stock; TMUS is a large-cap quality compounder stock; VZ is a mid-cap deep-value stock. TMUS, VZ pay a dividend while SURG, LBRDA, ATUS do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.